Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. Summary
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVARTIS AG
12:08pNOVARTISá : prostate cancer drug receives U.S. FDA breakthrough designation
RE
07:53aNOVARTISá : AlphaValue/Baader Europe Lifts Price Target on Novartis, Maintains A..
MT
06/15NOVARTIS AGá : Gets a Buy rating from Berenberg
MD
06/14NOVARTISá : investigational oral therapy iptacopan (LNP023) shows benefit as mon..
AQ
06/11NOVARTISá : Says Iptacopan Shows Benefits, Safety as Potential Treatment for Blo..
MT
06/11NOVARTIS'á : Iptacopan Shows Positive Results in Rare Blood Disorder Patients
MT
06/11PRESS RELEASEá : Novartis investigational oral -2-
DJ
06/11PRESS RELEASEá : Novartis investigational oral therapy iptacopan (LNP023) shows ..
DJ
06/11Novartis investigational oral therapy iptacopan (LNP023) shows benefit as mon..
DJ
06/11NOVARTIS'á : Entresto Gets Indication For High Blood Pressure Treatment In China
MT
06/09NOVARTISá : Mulls Swiss Plant Closure On Demand Shortage
MT
06/09NOVARTISá : to close Swiss plant, 50 jobs to go
RE
06/07NOVARTISá : Phase 2 Trial For Iptacopan Shows Positive Results in Kidney Disease..
MT
06/07NOVARTIS AGá : Credit Suisse sticks Neutral
MD
06/07NOVARTISá : announces new interim analysis Phase II data for iptacopan in rare k..
PU
More most relevant news
All news about NOVARTIS AG
05:07pCureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy
RE
12:08pNOVARTISá : prostate cancer drug receives U.S. FDA breakthrough designation
RE
07:53aNOVARTISá : AlphaValue/Baader Europe Lifts Price Target on Novartis, Maintains A..
MT
06/15NOVARTIS AGá : Gets a Buy rating from Berenberg
MD
06/14NOVARTISá : investigational oral therapy iptacopan (LNP023) shows benefit as mon..
AQ
06/11NOVARTISá : Says Iptacopan Shows Benefits, Safety as Potential Treatment for Blo..
MT
06/11NOVARTIS'á : Iptacopan Shows Positive Results in Rare Blood Disorder Patients
MT
06/11PRESS RELEASEá : Novartis investigational oral -2-
DJ
06/11PRESS RELEASEá : Novartis investigational oral therapy iptacopan (LNP023) shows ..
DJ
06/11Novartis investigational oral therapy iptacopan (LNP023) shows benefit as mon..
DJ
More news
News in other languages on NOVARTIS AG
12:16pBourse Zurich: nouveaux records du SMI, qui reste juste sous les 12'000 point..
12:16pAktien Schweiz: SMI bleibt unter 12'000 Punkten - Warten auf US-Notenbank
11:44aAktien Schweiz vor Fed etwas fester - SMI erneut mit Rekordhoch
11:22aNovartis erhält von FDA Therapiedurchbruch-Status zu Prostatakrebs-Kandidaten
11:19aNOVARTIS : statut de percée thérapeutique pour traiter le cancer de la prostate
05:30aBourse Zurich: la résistance des 12'000 points tient bon en fin de matinée
05:25aAktien Schweiz: Weiter fest, aber unter Tageshoch
02:44aMorning Briefing - Markt Schweiz
06/15Bourse Zurich: nouveaux records pour le SMI qui s'approche des 12'000 points
06/15Aktien Schweiz Schluss: SMI beisst sich an 12'000er-Marke Zähne aus
More news
Analyst Recommendations on NOVARTIS AG
07:53aNOVARTISá : AlphaValue/Baader Europe Lifts Price Target on Novartis, Maintains A..
MT
06/15NOVARTIS AGá : Gets a Buy rating from Berenberg
MD
06/07NOVARTIS AGá : Credit Suisse sticks Neutral
MD
06/04NOVARTISá : Morningstar Lifts Price Target on Novartis, Maintains Hold Recommend..
MT
06/04NOVARTIS AGá : JP Morgan reiterates its Sell rating
MD
More recommendations
Press releases
06/14NOVARTISá : investigational oral therapy iptacopan (LNP023) shows benefit as mon..
AQ
06/07NOVARTISá : announces new interim analysis Phase II data for iptacopan in rare k..
PU
06/03NOVARTISá : Kymriah pivotal trial demonstrates strong response rates and a remar..
AQ
05/27ETON PHARMACEUTICALSá : Particularity In Petitions Produces Positive Post-Grant ..
AQ
05/18NOVARTISá : Sandoz announces plans to further strengthen its antibiotics manufac..
AQ
More press releases
Upcoming event on NOVARTIS AG